WWH vs. HL, PCT, ATST, ABDN, 3IN, JGGI, PHLL, RCP, MNKS, and CTY
Should you be buying Worldwide Healthcare stock or one of its competitors? The main competitors of Worldwide Healthcare include Hargreaves Lansdown (HL), Polar Capital Technology Trust (PCT), Alliance Trust (ATST), abrdn (ABDN), 3i Infrastructure (3IN), JPMorgan Global Growth & Income (JGGI), Petershill Partners (PHLL), RIT Capital Partners (RCP), Monks (MNKS), and City of London (CTY). These companies are all part of the "asset management" industry.
Worldwide Healthcare vs. Its Competitors
Hargreaves Lansdown (LON:HL) and Worldwide Healthcare (LON:WWH) are both financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and media sentiment.
In the previous week, Worldwide Healthcare had 3 more articles in the media than Hargreaves Lansdown. MarketBeat recorded 4 mentions for Worldwide Healthcare and 1 mentions for Hargreaves Lansdown. Worldwide Healthcare's average media sentiment score of 1.48 beat Hargreaves Lansdown's score of 0.00 indicating that Worldwide Healthcare is being referred to more favorably in the news media.
Hargreaves Lansdown pays an annual dividend of GBX 43 per share. Worldwide Healthcare pays an annual dividend of GBX 0.03 per share and has a dividend yield of 0.0%. Hargreaves Lansdown pays out 6,935.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Worldwide Healthcare pays out -6.9% of its earnings in the form of a dividend. Worldwide Healthcare is clearly the better dividend stock, given its higher yield and lower payout ratio.
Hargreaves Lansdown has a beta of 0.66, indicating that its stock price is 34% less volatile than the S&P 500. Comparatively, Worldwide Healthcare has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500.
Hargreaves Lansdown has higher revenue and earnings than Worldwide Healthcare. Worldwide Healthcare is trading at a lower price-to-earnings ratio than Hargreaves Lansdown, indicating that it is currently the more affordable of the two stocks.
Worldwide Healthcare has a net margin of 92.78% compared to Hargreaves Lansdown's net margin of 82.61%. Hargreaves Lansdown's return on equity of 82.68% beat Worldwide Healthcare's return on equity.
66.7% of Hargreaves Lansdown shares are held by institutional investors. Comparatively, 10.2% of Worldwide Healthcare shares are held by institutional investors. 29.4% of Hargreaves Lansdown shares are held by company insiders. Comparatively, 0.2% of Worldwide Healthcare shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Hargreaves Lansdown beats Worldwide Healthcare on 9 of the 14 factors compared between the two stocks.
Get Worldwide Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for WWH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding WWH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Worldwide Healthcare Competitors List
Related Companies and Tools
This page (LON:WWH) was last updated on 10/4/2025 by MarketBeat.com Staff
